Publication: Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy (vol 43, 251, 2024)
dc.contributor.coauthor | He, Kewen | |
dc.contributor.coauthor | Puebla-Osorio, Nahum | |
dc.contributor.coauthor | Barsoumian, Hampartsoum B. | |
dc.contributor.coauthor | Rafq, Zahid | |
dc.contributor.coauthor | Riad, Thomas S. | |
dc.contributor.coauthor | Hu, Yun | |
dc.contributor.coauthor | Huang, Ailing | |
dc.contributor.coauthor | Voss, Tifany A. | |
dc.contributor.coauthor | Leyton, Claudia S. Kettlun | |
dc.contributor.coauthor | Schuda, Lily Jae | |
dc.contributor.coauthor | Hsu, Ethan | |
dc.contributor.coauthor | Heiber, Joshua | |
dc.contributor.coauthor | Cortez, Maria-Angelica | |
dc.contributor.coauthor | Welsh, James W. | |
dc.contributor.department | School of Medicine | |
dc.contributor.kuauthor | Sezen, Duygu | |
dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
dc.date.accessioned | 2025-03-06T20:59:05Z | |
dc.date.issued | 2024 | |
dc.description.indexedby | WOS | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.identifier.doi | 10.1186/s13046-024-03183-9 | |
dc.identifier.eissn | 1756-9966 | |
dc.identifier.issue | 1 | |
dc.identifier.quartile | Q1 | |
dc.identifier.scopus | 2-s2.0-85203429261 | |
dc.identifier.uri | https://doi.org/10.1186/s13046-024-03183-9 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/27627 | |
dc.identifier.volume | 43 | |
dc.identifier.wos | 1310009800001 | |
dc.keywords | Drug therapy | |
dc.keywords | Erratum | |
dc.keywords | Human | |
dc.keywords | Radiotherapy | |
dc.keywords | Surgery | |
dc.keywords | Controlled study | |
dc.keywords | Nonhuman | |
dc.language.iso | eng | |
dc.publisher | BMC | |
dc.relation.ispartof | Journal of Experimental and Clinical Cancer Research | |
dc.subject | Oncology | |
dc.title | Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy (vol 43, 251, 2024) | |
dc.type | Other | |
dc.type.other | Correction | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Sezen, Duygu | |
local.publication.orgunit1 | SCHOOL OF MEDICINE | |
local.publication.orgunit2 | School of Medicine | |
relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isOrgUnitOfPublication.latestForDiscovery | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
relation.isParentOrgUnitOfPublication.latestForDiscovery | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e |